Iradimed (IRMD) Current Leases (2019 - 2025)

Iradimed (IRMD) reported Current Leases of $59221.0 for Q1 2025, down 85.86% year-over-year from $418814.0 in Q1 2024, and down 61.36% quarter-over-quarter from $153264.0 in Q4 2024.

Iradimed (IRMD) Current Leases (2019 - 2025) Analysis & Trends

Iradimed (IRMD) has 7 years of Current Leases data on file, last reported at $59221.0 in Q1 2025.

  • Current Leases for Q1 2025 came in at $59221.0, down 85.86% year-over-year; the trailing twelve-month figure through Mar 2025 was $59221.0 (down 85.86% YoY), and the FY2024 annual result was $153264.0, down 64.19% from the prior year.
  • Current Leases fell to $59221.0 in Q1 2025 per IRMD's latest filing, from $153264.0 in the prior quarter.
  • Over five years, Current Leases peaked at $427963.0 in Q4 2023 and troughed at $59221.0 in Q1 2025.
  • A 5-year average of $303403.1 and a median of $284891.0 in 2022 frame the typical range for Current Leases.
  • The sharpest annual moves came in 2023 and 2025: Current Leases surged 45.83% in 2023, then sank 85.86% in 2025.
  • A 5-year view of Current Leases shows it stood at $276568.0 in 2021, then gained by 6.11% to $293466.0 in 2022, then surged by 45.83% to $427963.0 in 2023, then sank by 64.19% to $153264.0 in 2024, then slumped by 61.36% to $59221.0 in 2025.
  • Business Quant data shows IRMD's Current Leases at $59221.0 in Q1 2025, $153264.0 in Q4 2024, and $261244.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 35.80 Mn
10 Iradimed 1.18 Bn 1.12 Bn 16.81 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 59,221.00
Dec 31, 2024 153,264.00
Sep 30, 2024 261,244.00
Jun 30, 2024 367,618.00
Mar 31, 2024 418,814.00
Dec 31, 2023 427,963.00
Sep 30, 2023 421,379.00
Jun 30, 2023 413,745.00
Mar 31, 2023 409,295.00
Dec 31, 2022 293,466.00
Sep 30, 2022 289,147.00
Jun 30, 2022 284,891.00
Mar 31, 2022 280,698.00
Dec 31, 2021 276,568.00
Sep 30, 2021 272,498.00
Jun 30, 2021 268,488.00
Mar 31, 2021 259,553.00
Dec 31, 2020 255,698.00
Sep 30, 2020 251,901.00
Jun 30, 2020 248,159.00